THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 122 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,354,428 | -16.6% | 7,457,060 | 0.0% | 3.81% | -35.6% |
| Q2 2023 | $77,180,571 | -4.6% | 7,457,060 | 0.0% | 5.92% | +14.3% |
| Q1 2023 | $80,909,101 | -3.3% | 7,457,060 | 0.0% | 5.18% | +51.9% |
| Q4 2022 | $83,668,213 | +10.7% | 7,457,060 | 0.0% | 3.41% | +83.4% |
| Q3 2022 | $75,615,000 | +33.8% | 7,457,060 | +19.6% | 1.86% | +34.6% |
| Q2 2022 | $56,511,000 | +9.2% | 6,237,438 | +15.2% | 1.38% | +28.6% |
| Q1 2022 | $51,743,000 | +80.0% | 5,412,487 | +108.0% | 1.07% | +74.2% |
| Q4 2021 | $28,750,000 | – | 2,601,778 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |